or Try an Advanced Search...

    Castration Resistant Prostate Cancer Stocks List

    Symbol Grade Name % Change
    AMGN B Amgen Inc. 2.35
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Biotechnology Blood Cells Bone Bone Disease Cancer Care Clinic Dialysis Dow Jones Component Drugs Epidermal Growth Factor Receptor Growth Factors Healthcare Providers Hematology Human Therapeutic Products Inflammation Inflammatory Diseases Medicine Metastases Mimics Monoclonal Antibody

    Related ETFs - A few ETFs which own one or more of the above listed Castration Resistant Prostate Cancer stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 14.82
    IBB D iShares Nasdaq Biotechnology Index Fund 8.47
    IBBQ D Invesco Nasdaq Biotechnology ETF 8.4
    BIS A ProShares UltraShort Nasdaq Biotechnology 8.14
    BIB D ProShares Ultra Nasdaq Biotechnology 6.2
    View all Castration Resistant Prostate Cancer ETFs...
    Compare ETFs
    Compare BBH to BIB Compare IBB to IBBQ Compare IBBQ to BIS

        Castration Resistant Prostate Cancer Stocks Recent News

        Date Stock Title
        Apr 17 AMGN Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
        Apr 17 AMGN Can This High-Yield Dividend Stock Keep Beating the S&P 500?
        Apr 17 AMGN Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
        Apr 16 AMGN AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
        Apr 15 AMGN Amgen, Shell And More On CNBC's 'Final Trades'
        Apr 15 AMGN Amgen: I Prefer To Chase Value And Dividends
        Apr 15 AMGN Amgen: The Giant With An Impressive Pipeline
        Apr 13 AMGN AbbVie keeps Humira market share near 100% despite biosimilars: report
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Biotechnology Blood Cells Bone Bone Disease Cancer Care Clinic Dialysis Dow Jones Component Drugs Epidermal Growth Factor Receptor Growth Factors Healthcare Providers Hematology Human Therapeutic Products Inflammation Inflammatory Diseases Medicine Metastases Mimics Monoclonal Antibody
        Castration Resistant Prostate Cancer

        Castration-resistant prostate cancer (CRPC) is a type of prostate cancer that is resistant to hormone therapy, which is the primary treatment for prostate cancer. It is also known as hormone-refractory prostate cancer (HRPC). CRPC is an advanced form of prostate cancer that has spread beyond the prostate gland and is no longer responding to hormone therapy. It is usually treated with chemotherapy, radiation therapy, and other treatments.

        Browse All Tags